• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

New agents show promise in melanoma

Article

Tampa, Fla. — Among molecularly targeted agents being developed to treat melanoma, some of the most exciting are anti-CTLA-4 antibodies now being developed by Pfizer and Medarex.

Recent Videos
Related Content
Day 4 Recap: Maui Derm NP+PA Fall 2024

Day 4 Recap: Maui Derm NP+PA Fall 2024

Article
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Podcast
New Data Indicates DermaSensor Effectively Assists Primary Care Clinicians in Differentiating Between Cancerous and Benign Skin Lesions

New Data Indicates DermaSensor Effectively Assists Primary Care Clinicians in Differentiating Between Cancerous and Benign Skin Lesions

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
Donna Culton, MD, PhD: The Evolving Understanding of Blistering Disease

Donna Culton, MD, PhD: The Evolving Understanding of Blistering Disease

Article
Current Commonalities in Contact Dermatitis with Matthew Zirwas, MD

Current Commonalities in Contact Dermatitis with Matthew Zirwas, MD

Article
© 2024 MJH Life Sciences

All rights reserved.